LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Cytoplasmic Trafficking of Nanoparticles Delivers Plasmid DNA for Macrophage Gene-editing.

    Lee, So Yoon / Fierro, Javier / Tran, An M / Hong, Daewoo / Espinal, Jamil / Dou, Huanyu

    Current gene therapy

    2021  Volume 21, Issue 4, Page(s) 349–360

    Abstract: Background: Successful delivery of gene-editing tools using nano-carriers is dependent on the ability of nanoparticles to pass through the cellular membrane, move through the cytoplasm, and cross the nuclear envelope to enter the nucleus. It is critical ...

    Abstract Background: Successful delivery of gene-editing tools using nano-carriers is dependent on the ability of nanoparticles to pass through the cellular membrane, move through the cytoplasm, and cross the nuclear envelope to enter the nucleus. It is critical that intracellular nanoparticles interact with the cytoskeletal network to move toward the nucleus, and must escape degradation pathways including lysosomal digestion. Without efficient intracellular transportation and nuclear entry, nanoparticles-based gene-editing cannot be effectively used for targeted genomic modification.
    Objective: We have developed nanoparticles with a low molecular weight branched polyethylenimine lipid shell and a PLGA core that can effectively deliver plasmid DNA to macrophages for gene editing while limiting toxicity.
    Methods: Core-shell nanoparticles were synthesized by a modified solvent evaporation method and were loaded with plasmid DNA. Confocal microscopy was used to visualize the internalization, intracellular distribution and cytoplasmic transportation of plasmid DNA loaded nanoparticles (pDNA-NPs) in bone marrow-derived macrophages.
    Results: Core-shell nanoparticles had a high surface charge of +56 mV and narrow size distribution. When loaded with plasmid DNA for transfection, the nanoparticles increased in size from 150 nm to 200 nm, and the zeta potential decreased to +36 mV, indicating successful encapsulation. Further, fluorescence microscopy revealed that pDNA-NPs crossed the cell membrane and interacted with actin filaments. Intracellular tracking of pDNA-NPs showed successful separation of pDNA- NPs from lysosomes, allowing entry into the nucleus at 2 hours, with further nuclear ingress up to 5 hours. Bone marrow-derived macrophages treated with pDNA/GFP-NPs exhibited high GFP expression with low cytotoxicity.
    Conclusion: Together, this data suggests pDNA-NPs are an effective delivery system for macrophage gene-editing.
    MeSH term(s) Cytoplasm/genetics ; DNA/genetics ; Gene Editing ; Macrophages ; Nanoparticles ; Plasmids/genetics ; Polyethyleneimine ; Transfection
    Chemical Substances Polyethyleneimine (9002-98-6) ; DNA (9007-49-2)
    Language English
    Publishing date 2021-02-11
    Publishing country United Arab Emirates
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2146187-9
    ISSN 1875-5631 ; 1566-5232
    ISSN (online) 1875-5631
    ISSN 1566-5232
    DOI 10.2174/1566523221666210211101740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Engineering Human Circulating Monocytes/Macrophages by Systemic Deliverable Gene Editing.

    Lee, So Yoon / Fierro, Javier / Dipasquale, Jake / Bastian, Anthony / Tran, An M / Hong, Deawoo / Chin, Brandon / Nguyen-Lee, Paul J / Mazal, Sarah / Espinal, Jamil / Thomas, Tima / Dou, Huanyu

    Frontiers in immunology

    2022  Volume 13, Page(s) 754557

    Abstract: Delivery of plasmid DNA to transfect human primary macrophages is extremely difficult, especially for genetic engineering. Engineering macrophages is imperative for the treatment of many diseases including infectious diseases, cancer, neurological ... ...

    Abstract Delivery of plasmid DNA to transfect human primary macrophages is extremely difficult, especially for genetic engineering. Engineering macrophages is imperative for the treatment of many diseases including infectious diseases, cancer, neurological diseases, and aging. Unfortunately, plasmid does not cross the nuclear membranes of terminally differentiated macrophages to integrate the plasmid DNA (pDNA) into their genome. To address this issue, we have developed a core-shell nanoparticle (NP) using our newly created cationic lipid to deliver the anti-inflammatory cytokine IL-4 pDNA (IL-4pDNA-NPs). Human blood monocyte-derived macrophages (MDM) were effectively transfected with IL-4pDNA-NPs. IL-4pDNA-NPs were internalized in MDM within 30 minutes and delivered into the nucleus within 2 hours. Exogenous IL-4 expression was detected within 1 - 2 days and continued up to 30 days. Functional IL-4 expression led to M2 macrophage polarization
    MeSH term(s) Animals ; DNA/metabolism ; Gene Editing ; Humans ; Interleukin-4/genetics ; Interleukin-4/metabolism ; Macrophages/metabolism ; Mice ; Monocytes/metabolism
    Chemical Substances Interleukin-4 (207137-56-2) ; DNA (9007-49-2)
    Language English
    Publishing date 2022-05-18
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2022.754557
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top